K. Burri

发表

Analogues and Derivatives of Tenoxicam. Part 1. Synthesis and Antiinflammatory Activity of Analogues with Different Residues on the Ring Nitrogen and the Amide Nitrogen.

C. Noe, D. Binder, O. Hromatka, 1987 .

Analogues and derivatives of tenoxicam. 1. Synthesis and antiinflammatory activity of analogues with different residues on the ring nitrogen and the amide nitrogen.

C. Noe, D. Binder, O. Hromatka, 1987, Journal of medicinal chemistry.

Stereoselektive Umwandlung von [2.2.2.2.2.2]Metacyclophan in ein all‐trans‐Hexaen

K. Burri, W. Jenny, 1967 .

Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist

W. Neidhart, K. Burri, G. Gray, 1993, Nature.

In vitro characterisation of Ro 46‐8443, the first non‐peptide antagonist selective for the endothelin ETB receptor

W. Neidhart, K. Burri, V. Breu, 1996, FEBS letters.

The Discovery of Nonpeptide Endothelin Receptor Antagonists. Progression towards Bosentan

W. Neidhart, K. Burri, V. Breu, 1996, CHIMIA.

Discovery of Ro 48-5695: A potent mixed endothelin receptor antagonist optimized from bosentan

W. Neidhart, K. Burri, V. Breu, 1997 .

Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.

W. Neidhart, K. Burri, G. Gray, 1994, The Journal of pharmacology and experimental therapeutics.

[2.2. …] Metacyclophane

K. Burri, W. Jenny, 1967 .

Preparation of macrolides via the Wittig reaction. A total synthesis of (-)-vermiculine

K. Burri, P. Rosen, Robert A. Cardone, 1978 .

Tilcotil® Studies [3+2] additions with isothiazol‐3(2H)‐one 1,1‐dioxide

K. Burri, 1989 .

SULFONAMIDE-BASED ANTAGONISTS OF THE ENDOTHELIN RECEPTORS

W. Neidhart, K. Burri, A. Trzeciak, 1995, European Journal of Medicinal Chemistry.